摘要:
Disclosed herein are compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein R1 and R2 independently represent a hydrogen atom or a deuterium atom; R3' and R3" independently represent a hydrogen atom, a methyl group, a methoxy group, a chlorine atom, a fluorine atom, or a cyano group; R4 represents a hydrogen atom or a fluorine atom; R5 and R5' independently represent a hydrogen atom or a fluorine atom; (aa) represents -CH2-, -CH=, -CR8=, -O- or -NH-, wherein R8 represents a fluorine atom or a (C1-C3)alkyl group; represents a single bond or a double bond; X represents -CH=, -N= or -CR"=, wherein R" represents a (C1-C3)alkyl group or a halogen atom, such as a fluorine or a chlorine atom, a cyano group, or a (C1-C3)fluoroalkyl group, such as a trifluoromethyl; R7 independently represents a (C1-C3)alkyl group, such as a methyl group, a halogen atom, such as a fluorine atom, a cyano group, or a (C1-C3)fluoroalkyl group, such as a trifluoromethyl; and R6 represents an optionally substituted mono or bicyclic ring selected from a phenyl group, a 5- or 6-membered monocyclic heteroaryl group, and a 7-, 8-, 9- or 10-membered bicyclic heterocycle group. Further disclosed are process for preparing the same, pharmaceutical compositions comprising them as well as said compounds of formula (I) for use as an inhibitor and degrader of estrogen receptors, in particular in the treatment of ovulatory dysfunction, cancer, endometriosis, osteoporosis, benign prostatic hypertrophy or inflammation.